Quest Diagnostics Incorporated Common Stock (DGX) stock analysis

DGX · Quest Diagnostics Incorporated Common Stock

Latest recorded price: USD 262.34

Model-estimated fair value: USD 150.99. This assumption-based estimate is for general research and is not investment advice.

Sector and industry: Healthcare · Diagnostics & Research

At $262.34, DGX trades 73.7% above the model's base-case value of $150.99. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $116.15 in the conservative case and $190.45 in the optimistic case, with a valuation confidence score of 75/100. About 81% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth 3.7%, free cash flow margin 12.3%, ROIC 10.3%. The model flags 1 risk signal for this company.

Similar companies in Healthcare